Henriette Aksnes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Henriette Aksnes has a total of 114 co-authors. Here are the top co-authors by number of shared publications:
- Thomas Arnesen
Department of Biomedicine, University of Bergen, Bergen, Norway
20 shared publications Nina Glomnes
Department of Biomedicine, University of Bergen, Bergen, Norway; Department of Clinical Science, University of Bergen, Bergen, Norway
6 shared publications- Adrian Drazic
Department of Biomedicine, University of Bergen, N-5020 Bergen, Norway
4 shared publications Michaël Marie
Department of Molecular Biology, University of Bergen, 5020 Bergen, Norway
4 shared publications- Petra Van Damme
RIP Unit, Laboratory of Microbiology, Department of Biochemistry and Microbiology, Ghent University, 9000 Ghent, Belgium
4 shared publications - Kris Gevaert
Ghent University
3 shared publications
Latest Publications
- 11 August 2025
- Published by Elsevier
- Vol. 718, 129-165
N-terminal acetylation-specific antibodies: Specificity determination by mass spectrometry and utilization in in vitro acetylation assays
- 11 August 2025
- Published by Elsevier
- Vol. 718, 129-165
N-terminal acetylation-specific antibodies: Specificity determination by mass spectrometry and utilization in in vitro acetylation assays
- Open Access
- 9 May 2025
- Published by Oxford University Press (OUP) in Brain
- Vol. 148 (9) , 3085-3094
Understanding brain calcification via N-terminal acetylation at the Golgi apparatus
Primary familial brain calcification (PFBC) provides valuable insights into the mechanisms underlying brain calcification as it singles out the proteins that potentially are involved in the relevant cellular pathways. To date, seven genes have been linked to PFBC, and studying their encoded proteins marks an exciting new era in understanding the disease mechanisms, which may ultimately lead to therapeutic strategies to prevent brain calcification. With each new gene found to be associated with PFBC due to pathogenic variants, an additional level of understanding is achieved. Here, we highlight the most recently discovered PFBC gene, encoding the Golgi-localized N-terminal acetyltransferase NAA60. We explore the novel perspectives gained from the understanding of this enzyme’s molecular, cellular and physiological properties. Interestingly, NAA60 shares a critical role with the most frequent PFBC gene, SLC20A2. Both these proteins seem to be involved in maintaining the structural integrity of the Golgi apparatus, as deficiency in either protein leads to Golgi fragmentation. Altered Golgi morphology is therefore emerging as a new significant topic in PFBC research, and we here discuss this topic in relation to existing knowledge regarding Golgi rearrangements and dysfunction as a factor in neurodegenerative diseases.
- 9 May 2025
- Published by Oxford University Press (OUP) in Brain
- Vol. 148 (9) , 3085-3094
Open AccessUnderstanding brain calcification via N-terminal acetylation at the Golgi apparatus
Primary familial brain calcification (PFBC) provides valuable insights into the mechanisms underlying brain calcification as it singles out the proteins that potentially are involved in the relevant cellular pathways. To date, seven genes have been linked to PFBC, and studying their encoded proteins marks an exciting new era in understanding the disease mechanisms, which may ultimately lead to therapeutic strategies to prevent brain calcification. With each new gene found to be associated with PFBC due to pathogenic variants, an additional level of understanding is achieved. Here, we highlight the most recently discovered PFBC gene, encoding the Golgi-localized N-terminal acetyltransferase NAA60. We explore the novel perspectives gained from the understanding of this enzyme’s molecular, cellular and physiological properties. Interestingly, NAA60 shares a critical role with the most frequent PFBC gene, SLC20A2. Both these proteins seem to be involved in maintaining the structural integrity of the Golgi apparatus, as deficiency in either protein leads to Golgi fragmentation. Altered Golgi morphology is therefore emerging as a new significant topic in PFBC research, and we here discuss this topic in relation to existing knowledge regarding Golgi rearrangements and dysfunction as a factor in neurodegenerative diseases.
- Open Access
- 21 April 2025
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 145 (5)
Fahr's disease or primary familial brain calcification?
21.04.2025: Språkspalten - Sykdomsbetegnelser basert på egennavn er på vei ut.
- 21 April 2025
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 145 (5)
Open AccessFahr's disease or primary familial brain calcification?
21.04.2025: Språkspalten - Sykdomsbetegnelser basert på egennavn er på vei ut.
- Open Access
- 5 January 2025
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 31 (3) , 206-208
Pi-ecing together brain calcification mechanisms for therapeutic advancement
- 5 January 2025
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 31 (3) , 206-208
Open AccessPi-ecing together brain calcification mechanisms for therapeutic advancement
- Top Cited PapersOpen Access
- 13 March 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-20
Biallelic NAA60 variants with impaired N-terminal acetylation capacity cause autosomal recessive primary familial brain calcifications
Primary familial brain calcification (PFBC) is characterized by calcium deposition in the brain, causing progressive movement disorders, psychiatric symptoms, and cognitive decline. PFBC is a heterogeneous disorder currently linked to variants in six different genes, but most patients remain genetically undiagnosed. Here, we identify biallelic NAA60 variants in ten individuals from seven families with autosomal recessive PFBC. The NAA60 variants lead to loss-of-function with lack of protein N-terminal (Nt)-acetylation activity. We show that the phosphate importer SLC20A2 is a substrate of NAA60 in vitro. In cells, loss of NAA60 caused reduced surface levels of SLC20A2 and a reduction in extracellular phosphate uptake. This study establishes NAA60 as a causal gene for PFBC, provides a possible biochemical explanation of its disease-causing mechanisms and underscores NAA60-mediated Nt-acetylation of transmembrane proteins as a fundamental process for healthy neurobiological functioning.
- 13 March 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-20
Top Cited PapersOpen AccessBiallelic NAA60 variants with impaired N-terminal acetylation capacity cause autosomal recessive primary familial brain calcifications
Primary familial brain calcification (PFBC) is characterized by calcium deposition in the brain, causing progressive movement disorders, psychiatric symptoms, and cognitive decline. PFBC is a heterogeneous disorder currently linked to variants in six different genes, but most patients remain genetically undiagnosed. Here, we identify biallelic NAA60 variants in ten individuals from seven families with autosomal recessive PFBC. The NAA60 variants lead to loss-of-function with lack of protein N-terminal (Nt)-acetylation activity. We show that the phosphate importer SLC20A2 is a substrate of NAA60 in vitro. In cells, loss of NAA60 caused reduced surface levels of SLC20A2 and a reduction in extracellular phosphate uptake. This study establishes NAA60 as a causal gene for PFBC, provides a possible biochemical explanation of its disease-causing mechanisms and underscores NAA60-mediated Nt-acetylation of transmembrane proteins as a fundamental process for healthy neurobiological functioning.
- Open Access
- 27 July 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-16
Loss of N-terminal acetyltransferase A activity induces thermally unstable ribosomal proteins and increases their turnover in Saccharomyces cerevisiae
Protein N-terminal (Nt) acetylation is one of the most abundant modifications in eukaryotes, covering ~50-80 % of the proteome, depending on species. Cells with defective Nt-acetylation display a wide array of phenotypes such as impaired growth, mating defects and increased stress sensitivity. However, the pleiotropic nature of these effects has hampered our understanding of the functional impact of protein Nt-acetylation. The main enzyme responsible for Nt-acetylation throughout the eukaryotic kingdom is the N-terminal acetyltransferase NatA. Here we employ a multi-dimensional proteomics approach to analyze Saccharomyces cerevisiae lacking NatA activity, which causes global proteome remodeling. Pulsed-SILAC experiments reveals that NatA-deficient strains consistently increase degradation of ribosomal proteins compared to wild type. Explaining this phenomenon, thermal proteome profiling uncovers decreased thermostability of ribosomes in NatA-knockouts. Our data are in agreement with a role for Nt-acetylation in promoting stability for parts of the proteome by enhancing the avidity of protein-protein interactions and folding.
- 27 July 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-16
Open AccessLoss of N-terminal acetyltransferase A activity induces thermally unstable ribosomal proteins and increases their turnover in Saccharomyces cerevisiae
Protein N-terminal (Nt) acetylation is one of the most abundant modifications in eukaryotes, covering ~50-80 % of the proteome, depending on species. Cells with defective Nt-acetylation display a wide array of phenotypes such as impaired growth, mating defects and increased stress sensitivity. However, the pleiotropic nature of these effects has hampered our understanding of the functional impact of protein Nt-acetylation. The main enzyme responsible for Nt-acetylation throughout the eukaryotic kingdom is the N-terminal acetyltransferase NatA. Here we employ a multi-dimensional proteomics approach to analyze Saccharomyces cerevisiae lacking NatA activity, which causes global proteome remodeling. Pulsed-SILAC experiments reveals that NatA-deficient strains consistently increase degradation of ribosomal proteins compared to wild type. Explaining this phenomenon, thermal proteome profiling uncovers decreased thermostability of ribosomes in NatA-knockouts. Our data are in agreement with a role for Nt-acetylation in promoting stability for parts of the proteome by enhancing the avidity of protein-protein interactions and folding.
- 15 July 2023
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 136 (14)
NATs at a glance
Most proteins receive an acetyl group at the N terminus while in their nascency as the result of modification by co-translationally acting N-terminal acetyltransferases (NATs). The N-terminal acetyl group can influence several aspects of protein functionality. From studies of NAT-lacking cells, it is evident that several cellular processes are affected by this modification. More recently, an increasing number of genetic cases have demonstrated that N-terminal acetylation has crucial roles in human physiology and pathology. In this Cell Science at a Glance and the accompanying poster, we provide an overview of the human NAT enzymes and their properties, substrate coverage, cellular roles and connections to human disease.
- 15 July 2023
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 136 (14)
NATs at a glance
Most proteins receive an acetyl group at the N terminus while in their nascency as the result of modification by co-translationally acting N-terminal acetyltransferases (NATs). The N-terminal acetyl group can influence several aspects of protein functionality. From studies of NAT-lacking cells, it is evident that several cellular processes are affected by this modification. More recently, an increasing number of genetic cases have demonstrated that N-terminal acetylation has crucial roles in human physiology and pathology. In this Cell Science at a Glance and the accompanying poster, we provide an overview of the human NAT enzymes and their properties, substrate coverage, cellular roles and connections to human disease.
- 29 March 2023
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 48 (6) , 495-499
Protein Termini 2022: central roles of protein ends
- 29 March 2023
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 48 (6) , 495-499
Protein Termini 2022: central roles of protein ends
- Open Access
- 17 February 2023
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 48 (5) , 414-416
Actin finally matures: uncovering machinery and impact
- 17 February 2023
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 48 (5) , 414-416
Open AccessActin finally matures: uncovering machinery and impact